Unknown

Dataset Information

0

Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei.

ABSTRACT: There is an urgent need for new, brain penetrant small molecules that target the central nervous system second stage of human African trypanosomiasis (HAT). We report that a series of novel indoline-2-carboxamides have been identified as inhibitors of Trypanosoma brucei from screening of a focused protease library against Trypanosoma brucei brucei in culture. We describe the optimization and characterization of this series. Potent antiproliferative activity was observed. The series demonstrated excellent pharmacokinetic properties, full cures in a stage 1 mouse model of HAT, and a partial cure in a stage 2 mouse model of HAT. Lack of tolerability prevented delivery of a fully curative regimen in the stage 2 mouse model and thus further progress of this series.

SUBMITTER: Cleghorn LA 

PROVIDER: S-EPMC4601051 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei.

Cleghorn Laura A T LA   Albrecht Sébastien S   Stojanovski Laste L   Simeons Frederick R J FR   Norval Suzanne S   Kime Robert R   Collie Iain T IT   De Rycker Manu M   Campbell Lorna L   Hallyburton Irene I   Frearson Julie A JA   Wyatt Paul G PG   Read Kevin D KD   Gilbert Ian H IH  

Journal of medicinal chemistry 20150929 19

There is an urgent need for new, brain penetrant small molecules that target the central nervous system second stage of human African trypanosomiasis (HAT). We report that a series of novel indoline-2-carboxamides have been identified as inhibitors of Trypanosoma brucei from screening of a focused protease library against Trypanosoma brucei brucei in culture. We describe the optimization and characterization of this series. Potent antiproliferative activity was observed. The series demonstrated  ...[more]

Similar Datasets

Unknown Discovery of Potent <i>N</i>-Ethylurea Pyrazole Derivatives as Dual Inhibitors of <i>Trypanosoma brucei</i> and <i>Trypanosoma cruzi</i>.
| S-EPMC7073874 | biostudies-literature
Unknown Discovery of potent and selective inhibitors of Trypanosoma brucei ornithine decarboxylase.
| S-EPMC2878083 | biostudies-literature
Unknown Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia.
| S-EPMC4025856 | biostudies-other
Unknown Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregation.
| S-EPMC2872922 | biostudies-literature
Unknown Computer-aided discovery of Trypanosoma brucei RNA-editing terminal uridylyl transferase 2 inhibitors.
| S-EPMC4317284 | biostudies-literature
Unknown Discovery of N-(2-aminoethyl)-N-benzyloxyphenyl benzamides: New potent Trypanosoma brucei inhibitors.
| S-EPMC5419589 | biostudies-literature
Unknown Activity of Bisnaphthalimidopropyl Derivatives against Trypanosoma brucei.
| S-EPMC4808195 | biostudies-literature
Unknown Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: discovery, synthesis, and characterization of their binding mode by protein crystallography.
| S-EPMC3188286 | biostudies-literature
Unknown Discovery of drug-like inhibitors of an essential RNA-editing ligase in Trypanosoma brucei.
| S-EPMC2577703 | biostudies-literature
Unknown Discovery of Inhibitors of Trypanosoma brucei by Phenotypic Screening of a Focused Protein Kinase Library.
| S-EPMC4648050 | biostudies-literature